Business

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

AbbVie (NYSE: ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.

articleAbbvie Inc.January 5, 20261/company/abbvie-inc/news/abbvie-to-present-at-the-44th-annual-jp-morgan-healthcare-conference
AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

About this update from Abbvie Inc.

[{"type":"text","content":"NORTH CHICAGO, Ill., Jan. 5, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.","length":242,"tagName":"p"},{"type":"text","content":"A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.","length":201,"tagName":"p"},{"type":"text","content":"About AbbVie","length":12,"tagName":"p"},{"type":"text","content":"AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.","length":542,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:TOP;TEXT-ALIGN:LEFT;","val":[{"type":"text","content":"Media:","length":6,"tagName":"p","attribs":{}},{"type":"text","content":"Gabby Tarbert ","length":13,"tagName":"p","attribs":{}},{"type":"text","content":"(224) [email protected]","length":43,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:TOP;TEXT-ALIGN:LEFT;","val":[{"type":"text","content":"Investors:","length":10,"tagName":"p","attribs":{}},{"type":"text","content":"Liz Shea ","length":8,"tagName":"p","attribs":{}},{"type":"text","content":"(847) [email protected]","length":34,"tagName":"p","attribs":{}}]}]}],"length":117},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"image","alt":"Cision","displaySize":"","headline":null,"caption":"Cision","className":"","disableSlideshowImg":false,"size":{"original":{"width":16,"height":16,"url":"https://media.zenfs.com/en/prnewswire.com/fed558a259ce4691b403d42282ff5e52"},"resized":{"url":"https://...

More updates from Abbvie Inc.

AbbViefireside chatInvestor Relations websiteMorgan Healthcare ConferencePRNewswire44th